Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 188

1.

Comparison of the antiviral effects of entecavir and adefovir dipivoxil in chronic HBV infection: a randomized control trial.

Jiang YF, He B, Ma J, Li NP, Gong GZ, Cheng D.

Acta Gastroenterol Belg. 2012 Sep;75(3):316-21.

PMID:
23082701
[PubMed - indexed for MEDLINE]
2.

[Entecavir 1.0mg monotherapy or entecavir plus adefovir dipivoxil for patients with lamivudine-resistant chronic hepatitis B had suboptimal response to lamivudine plus adefovir dipivoxil].

Xing J, Han T, Liu L, Li Y, Li J, Li Y, Xiao SX.

Zhonghua Gan Zang Bing Za Zhi. 2011 Nov;19(11):828-32. doi: 10.3760/cma.j.issn.1007-3418.2011.11.009. Chinese.

PMID:
22433304
[PubMed - indexed for MEDLINE]
3.

Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil.

Lu JJ, Liu K, Ma YJ, Wang J, Chen EQ, Tang H.

J Viral Hepat. 2013 Apr;20 Suppl 1:40-5. doi: 10.1111/jvh.12062.

PMID:
23458523
[PubMed - indexed for MEDLINE]
4.

De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis.

Lian JS, Zeng LY, Chen JY, Jia HY, Zhang YM, Xiang DR, Yu L, Hu JH, Lu YF, Zheng L, Li LJ, Yang YD.

World J Gastroenterol. 2013 Oct 7;19(37):6278-83. doi: 10.3748/wjg.v19.i37.6278.

PMID:
24115827
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir.

Lee JM, Kim HJ, Park JY, Lee CK, Kim do Y, Kim JK, Lee HW, Paik YH, Lee KS, Han KH, Chon CY, Hong SP, Nguyen T, Ahn SH.

Antivir Ther. 2009;14(5):705-12.

PMID:
19704174
[PubMed - indexed for MEDLINE]
6.

High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B.

Chae HB, Kim MJ, Seo EG, Choi YH, Lee HS, Han JH, Yoon SM, Park SM, Youn SJ.

Korean J Hepatol. 2012 Mar;18(1):75-83. doi: 10.3350/kjhep.2012.18.1.75. Epub 2012 Mar 22.

PMID:
22511906
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir.

Leung N, Peng CY, Hann HW, Sollano J, Lao-Tan J, Hsu CW, Lesmana L, Yuen MF, Jeffers L, Sherman M, Min A, Mencarini K, Diva U, Cross A, Wilber R, Lopez-Talavera J.

Hepatology. 2009 Jan;49(1):72-9. doi: 10.1002/hep.22658.

PMID:
19065670
[PubMed - indexed for MEDLINE]
8.

Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy.

Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI.

J Gastroenterol Hepatol. 2010 Aug;25(8):1374-80. doi: 10.1111/j.1440-1746.2010.06381.x.

PMID:
20659226
[PubMed - indexed for MEDLINE]
9.

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

PMID:
16904047
[PubMed - indexed for MEDLINE]
Free Article
10.

Combination lamivudine and adefovir versus entecavir for the treatment of naïve chronic hepatitis B patients: a pilot study.

Du QW, Ding JG, Sun QF, Hong L, Cai FJ, Zhou QQ, Wu YH, Fu RQ.

Med Sci Monit. 2013 Sep 9;19:751-6. doi: 10.12659/MSM.889443.

PMID:
24019010
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Efficacy of 2years of entecavir plus adefovir therapy in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analog treatment.

Wang X, Zhang C, Zhu Y, Xiong Y, Wang Y.

Antiviral Res. 2014 Mar;103:71-7. doi: 10.1016/j.antiviral.2014.01.009. Epub 2014 Jan 23.

PMID:
24462954
[PubMed - indexed for MEDLINE]
12.

[Three year adefovir dipivoxil treatment for hepatitis B e antigen-positive chronic hepatitis B patients].

Ling N, Zhou Z, Zhang DZ, Ren H.

Zhonghua Gan Zang Bing Za Zhi. 2007 May;15(5):346-9. Chinese.

PMID:
17524266
[PubMed - indexed for MEDLINE]
13.

Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.

Shim JH, Suh DJ, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS.

Hepatology. 2009 Oct;50(4):1064-71. doi: 10.1002/hep.23145.

PMID:
19637288
[PubMed - indexed for MEDLINE]
14.
15.

Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B.

Park MS, Kim BK, Kim KS, Kim JK, Kim SU, Park JY, Kim do Y, Baartarkhuu O, Han KH, Chon CY, Ahn SH.

Clin Mol Hepatol. 2013 Mar;19(1):29-35. doi: 10.3350/cmh.2013.19.1.29. Epub 2013 Mar 25.

PMID:
23593607
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Regulatory T-cell responses in chronic hepatitis B patients treated with nucleos(t)ide analogs compared with healthy subjects and untreated infected individuals.

Chen LY, Zhu LY, Yang BS, Bi MR, Yan BZ, Wang W, Ma YJ.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2582-6.

PMID:
22626879
[PubMed - indexed for MEDLINE]
17.

Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.

Pellicelli AM, Barbaro G, Francavilla R, Romano M, Barbarini G, Mazzoni E, Mecenate F, Paffetti A, Barlattani A, Struglia C, Villani R, Nauri L, Nosotti L, Armignacco O, Ferri F, Camporiondo MP, Soccorsi F; Club Epatologi Ospedalieri (CLEO) Group.

Clin Ther. 2008 Feb;30(2):317-23. doi: 10.1016/j.clinthera.2008.02.012.

PMID:
18343270
[PubMed - indexed for MEDLINE]
18.

Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir.

Son CY, Ryu HJ, Lee JM, Ahn SH, Kim do Y, Lee MH, Han KH, Chon CY, Park JY.

Liver Int. 2012 Aug;32(7):1179-85. doi: 10.1111/j.1478-3231.2012.02793.x. Epub 2012 Mar 27.

PMID:
22452737
[PubMed - indexed for MEDLINE]
19.

Entecavir 1mg versus combined lamivudine/adefovir dipivoxil in chronic HBV Egyptian patients resistant to LAM monotherapy, non-randomised controlled study.

Maklad S, Doss W, El Din SS, Hassan K, Zeid AA.

Arab J Gastroenterol. 2014 Mar;15(1):1-5. doi: 10.1016/j.ajg.2014.01.003. Epub 2014 Feb 4.

PMID:
24630505
[PubMed - indexed for MEDLINE]
20.

Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance.

Yang HJ, Lee JH, Kim YJ, Yoon JH, Lee HS.

J Med Virol. 2012 Mar;84(3):424-30. doi: 10.1002/jmv.23229.

PMID:
22246827
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk